Musk’s Terafab Vision and Analyst Upgrades Present Conflicting Currents for ASML

Elon Musk calls ASML Europe's most important company; stock drops 5.75% amid sector rout but analysts raise targets on EUV monopoly and upcoming Terafab project.

Elon Musk tipped ASML as “probably Europe’s most important company” on Saturday — a ringing endorsement that landed just 24 hours after the Dutch lithography giant suffered its sharpest single-session drop in weeks. The timing is hardly coincidental: Musk is due to speak at ASML’s internal technology conference on June 11-12, where he is expected to unveil details of the ambitious Terafab project. That appearance could prove a powerful catalyst for sentiment, depending on whether the Tesla and SpaceX boss commits to concrete equipment orders.

The stock closed Friday at €1,429.40, down 5.75%, as a sector-wide rout triggered by weak guidance from Broadcom and a surprisingly strong US jobs report erased what had been a fresh record high of €1,529.80 just the day before. Even after that pullback, ASML shares still boast a year-to-date gain of nearly 45%, a testament to the underlying demand story that has drawn a flurry of upward analyst revisions.

Analyst Targets Keep Climbing Despite the Selloff

Remarkably, the Friday drop came on the heels of several price-target increases. BofA Securities raised its target from €1,710 to €1,921 with a “Buy” rating, while Barclays moved from €1,575 to €1,900, maintaining an “Overweight” stance. JPMorgan had lifted its target to $2,200 (from $1,813) a day earlier, also “Overweight,” citing a “clearly more positive” tone from management. Morgan Stanley followed with an increase to €1,660 from €1,400.

All the upgrades hinge on one core thesis: ASML’s monopoly on extreme ultraviolet (EUV) lithography systems ensures multiyear visibility, with BofA forecasting 2028 revenue of €58.9 billion, adjusted EPS of €59.54, and a gross margin of 56% — up from 52.6% projected for this year. The bank sees the company pushing EUV production beyond previously assumed capacity limits, supported by the hiring of field technicians that accelerated from the fourth quarter of 2025.

Terafab: A Tangible Demand Engine

Musk’s Terafab project — a vertically integrated semiconductor venture jointly announced by Tesla, SpaceX, and xAI in March 2026 — would be a direct beneficiary of ASML’s EUV systems. Intel joined the initiative in April, contributing its 14A process technology, and SpaceX has already applied for a manufacturing site in Grimes County, Texas, with an investment envelope of up to $119 billion. ASML CEO Christophe Fouquet, who has met Musk personally, described the undertaking as “serious” and expects the first logic chips made with ASML’s High-NA EUV tools to appear before year-end. A confirmation of that timeline during the conference would mark a technological milestone for the entire industry.

Beyond Terafab, the broader capacity expansion is already visible in the supply chain. Jenoptik reported robust lithography orders in the first quarter of 2026 and plans to bring new clean-room capacity online in 2027. Aalberts has also committed capital specifically for future EUV growth.

Balancing Growth with Regulatory Uncertainty

Fouquet has taken a vocal stance against overregulation even as he supports parts of the European Union’s latest technology package — including the Chips Act 2.0, the Cloud and AI Development Act, and an open-source strategy. In a LinkedIn post, he warned that steering strategic projects “must fundamentally respond to industry needs” and that the risk of “overcomplication” should be avoided. He has also publicly opposed the US MATCH Act, which would ban the sale and servicing of DUV immersion systems to Chinese customers, arguing that further restrictions would merely accelerate China’s domestic development. Any legislative movement in Washington remains an open risk for the stock.

Financials and the Next Catalyst

ASML’s fundamentals remain solid. In the first quarter of 2026, the company posted revenue of €8.8 billion and net profit of €2.8 billion. Full-year guidance calls for sales between €36 billion and €40 billion with a gross margin of 51% to 53%. For the second quarter, management expects revenue of €8.4 billion to €9.0 billion and a gross margin of 51% to 52%.

The June 11-12 conference will be the immediate test of sentiment, especially regarding whether Musk translates his endorsement into binding purchase commitments. The next major check on fundamentals arrives July 15, when ASML reports second-quarter results. Until then, the stock sits at the intersection of bullish capacity bets and lingering geopolitical fears — a tension that will only sharpen as those two dates approach.